h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
REGUi003-A
Registration Summary
:
A
P
E
C
WERNER iPSC
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
REGUi003-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
REGUi003-A (RRID:CVCL_XC58)
Alternative name(s)
WERNER iPSC
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
21st November 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Institute for Regenerative Medecine & Biotherapy U1183 (REGU)
External Databases
Cellosaurus
CVCL_XC58
Wikidata
Q98128894
General Information
Publications
Gatinois V et al. Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere length. Stem cell research. 2019 Aug;39:101515.
Cheung Hoi-Hung et al. Werner syndrome induced pluripotent stem cells, a study of pathologic aging. Recent Advances in iPSC Disease Modeling, Volume 1. 2020-00-00.
Lu L et al. RECQ DNA Helicases and Osteosarcoma. Advances in experimental medicine and biology. 2020;1258:37-54.
Gatinois V et al. iPSC line derived from a Bloom syndrome patient retains an increased disease-specific sister-chromatid exchange activity. Stem cell research. 2020 Mar;43:101696.
Pichard L et al. Generation of human pluripotent stem cell lines (iPSCs) from mesenchymal stem cells (MSCs) from three elderly patients with osteoarthritis. Stem cell research. 2020 Apr;44:101721.
Gatinois V et al. iPSC reprogramming of fibroblasts from a patient with a Rothmund-Thomson syndrome RTS. Stem cell research. 2020 May;45:101807.
Souidi M et al. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). Stem cell research. 2020 Dec;49:102094.
Alle Q et al. Reprogramming: Emerging Strategies to Rejuvenate Aging Cells and Tissues. International journal of molecular sciences. 2021 Apr 13;22(8).
Wang Z et al. Current status and future prospects of patient-derived induced pluripotent stem cells. Human cell. 2021 Nov;34(6):1601-1616.
Ray A et al. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells. Stem cell reviews and reports. 2021 Dec;17(6):1954-1974.
Colombani S et al. Generation of catecholaminergic polymorphic ventricular tachycardia patient-specific induced pluripotent stem cell line. Stem cell research. 2022 Apr;60:102727.
Milosic Filip et al. Premature aging in genetic diseases: what conclusions can be drawn for physiological aging. Frontiers in Aging. 2024-02-28.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.